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Antibody diversity: A link between switching and hypermutation
Michael Lieber
Recent work indicates that mutations in a cytidine
deaminase homologue ablate both immunoglobulin
class switch recombination and somatic hypermutation.
These findings now explain cases of autosomal
hyper-IgM syndrome and reveal that critical components
for key functions of B cells require RNA editing. 
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During lymphocyte differentiation, three covalent modifi-
cations take place at the antigen receptor gene loci to gen-
erate immunological diversity. V(D)J recombination is the
process by which the exon encoding the antigen-binding
pocket of the receptor is assembled, occurring in B cells at
the three immunoglobulin (Ig) loci (heavy chain, and
kappa and lambda light chain loci) and in T cells at the
three T-cell receptor loci (α/δ, γ and β loci). Class switch
recombination occurs only at the Ig heavy chain locus in B
cells, and it is the DNA recombination process by which
production of the IgG, IgA, and IgE antibodies can occur
instead of IgM. Somatic hypermutation is the process by
which point mutations are introduced into the V(D)J exon
in Ig genes in B cells as a way of creating additional diver-
sity beyond the combinatorial and junctional diversity
achieved by V(D)J recombination. Somatic hypermutation
improves the affinity of Ig molecules, and it occurs at the
Ig heavy and light chain genes [1]. 
Although many aspects of V(D)J recombination are now
well-understood, progress on the mechanistic aspects of
class switch recombination and somatic hypermutation has
been much more difficult. This is not entirely unexpected.
The cleavage phase of V(D)J recombination is precisely at
the boundary of a defined signal sequence, and the reac-
tion mechanism falls into the well-studied category of
DNA transposition [2]. In marked contrast, class switching
is a regionally specific recombination process that occurs at
G-rich, repetitive regions under conditions of transcription
[3,4]. There is no real precedent for this type of recombi-
nation elsewhere in biology. Likewise, somatic hypermu-
tation is a regionally specific mutation process with no
obvious precedent in other biological systems [5]. 
At the DNA level, the mechanisms of class switch and
somatic hypermutation have been unclear. Transcription
appears to be important for class switch recombination
because special promoters are present upstream of each
switch region for the purpose of sending transcripts
through these regions at about the time of the recombina-
tion [4]. The switch regions are several kilobases long and
contain highly repetitive, G-rich sequences. RNA–DNA
hybrids form at such sequences in vitro [6,7], but evidence
for such a structure in vivo has yet to be found. Class
switch recombination can occur anywhere within the
several kilobases of each switch region [3]. The nuclease
responsible for this process has yet to be identified, and it
is also unclear what sequence or structure that nuclease
might recognize. Somatic hypermutation also appears to
require transcription and the presence of one of the Ig
enhancers [5]. Any promoter appears to be suitable, even
an RNA polymerase I promoter [8]. Recently, strand
breaks have been identified in one cell line that carries out
somatic hypermutation in culture, but the significance of
this is not clear at this stage [9]. 
The Honjo laboratory has had a longstanding role in under-
standing class switch recombination, identifying many of
the original class switch sequences two decades ago [10].
More recently, this group carried out a cDNA subtraction
analysis of a switch-stimulated and -unstimulated cell line
[11]. Among three newly identified cDNAs was one with
homology to the cytidine deaminase that acts on the
apolipoprotein (apo) B mRNA generating a smaller isoform
of the protein. The authors called this gene the activation-
induced deaminase, or AID, and its expression nicely
matched that of cells carrying out class switch recombina-
tion. The protein is expressed in lymph nodes and spleen,
but not in thymus, brain, kidney, liver, testis, lung, heart,
or muscle. The protein has the ability to convert cytidine
and deoxycytidine nucleosides to uridine and deoxyuridine
nucleosides. Although it was not clear what the natural
target mRNA might be for AID, the discovery of an RNA-
editing enzyme homologue that was specific to germinal
center B cells, which undergo extensive proliferation and
maturation, was quite exciting in itself.
The most recent dramatic chapter to this story occurred
when Honjo and colleagues [12] made a murine genetic
knockout of AID. They found that the mice could not
make IgG, IgA, or IgE, even when provided with a strong,
specific antigenic challenge. The B cells from the mice,
when stimulated in culture, were also unable to generate
class-switched immunoglobulins or to show any evidence
of recombination at the DNA level. Strikingly, the mice
could not carry out another major DNA modification —
somatic hypermutation of their immunoglobulin genes. In
some manner, therefore, AID is critical to both class
switch recombination and somatic hypermutation. 
Remarkably, major progress of a related nature was being
made concurrently in the Durandy laboratory [13] in Paris
on the human hyper-IgM syndrome, a disease charac-
terised by a predominance of IgM antibodies. An X-linked
form of hyper-IgM syndrome can be caused by a signaling
defect in the CD40 ligand, which is expressed on T cells
and certain other immune cells and regulates various
immune functions when bound to its partner, CD40. The
result is that the CD40 molecule on the B cells then fails
to have a functional ligand on these other immune cells,
and class switching fails to be stimulated, along with other
aspects of terminal B-cell differentiation. Failure of
switching results in accumulation of IgM instead of IgG,
IgA or IgE. Durandy and colleagues have been studying
an autosomal recessive form of hyper-IgM syndrome. In
these patients, CD40 and its ligand are normally
expressed, along with related signaling molecules, reveal-
ing that a different molecule is affected. 
In order to track down the gene defective in the autosomal
form of the syndrome, Durandy and colleagues performed
linkage analysis using microsatellite markers in affected
families. Their search narrowed their focus on a 4.5 cM
region of chromosome 12p13, which happened to be where
the Honjo group had recently mapped the AID gene in the
human genome [14]. The Tokyo and Paris groups shared
their information in an effort to test the AID gene in the
hyper-IgM families. The Durandy laboratory sequenced
the 5 exons of AID and the adjacent intronic regions in
their 18 patients. Strikingly, they found 10 independent
mutations among the patients, and the patterns of inheri-
tance explained the hyper-IgM syndrome. 
The immunological characteristics of the patients are
interesting. In addition to being deficient in IgG, IgA or
IgE and having elevated IgM, they have other abnormali-
ties. The level of somatic hypermutation, as might be
expected from the murine knockout, is markedly reduced.
Histologically, the patients have markedly enlarged ger-
minal centers. Interestingly, many of these germinal
center B cells expressed not only IgM but also IgD: cells
expressing this Ig type are not usually abundant in normal
reactive germinal centers.
Clearly, the AID protein plays an important role in B-cell
differentiation, because its absence and mutation ablates
class switch recombination and somatic hypermutation
and alters germinal center dynamics. The natural next
question is what mRNA might this cytidine deaminase be
altering to have such dramatic effects. The possibilities
are all interesting, of course (Figure 1). First, given that
the AID gene appears to be a member of the RNA-editing
cytidine deaminases, it is reasonable to assume that it is
indeed changing the sequence of some mRNA that
encodes a key component in terminal B-cell differentia-
tion. That key component would then be expressed in a
different form. The editing could result in an active
mRNA, or the editing might result in inactivation of some
inhibitor that was previously blocking progression of the
B-cell differentiation program.
A second set of possibilities is that AID itself is one of the
enzymatic components for the DNA recombination and
mutation steps of both class switch and somatic hypermu-
tation. AID is rather small, however — about 24 kDa —
and it is difficult to imagine, though not impossible, that a
protein of this size could have cytidine deaminase, nucle-
ase and mutation activities. But it could be a structural
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Figure 1
Possible roles for activation-induced
cytidine deaminase in class switching and
somatic hypermutation.
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component of a larger complex that acts on DNA to
achieve recombination and mutation. In this regard, it is
noteworthy that some RNA-editing enzymes bind prefer-
entially to non-B-form DNA conformations [15] and that
unusual nucleic acid structures form at class switch
sequences when transcribed in purified systems [6,7,16]. 
It is interesting that the enzyme apobec-1, which edits the
apo B mRNA, requires another protein, the apobec-1
complementation factor (ACF), in order to bind to the apo
B mRNA. Both apobec-1 and ACF are required for
editing of the apo B mRNA in vitro. There is an 11
nucleotide mooring sequence that targets the editing in
the apo B mRNA. ACF is expressed in other tissues,
including lymphoid tissues, even though apobec-1 is not.
Based on this precedent, it is conceivable that ACF or
another equivalent factor helps AID recognize another
mRNA containing the ACF mooring sequence that is
important in B-cell differentiation or in the catalysis of
class switch and somatic hypermutation.
In considering the possible roles of AID, it is worth noting
that class switch recombination only occurs at the heavy
chain locus at class switch sequences, whereas somatic
hypermutation occurs at the kappa and lambda light chain
loci as well as at the heavy chain locus. There does not
appear to be a fundamental way in which switch recombi-
nation and somatic hypermutation could be linked in
terms of the mechanism by which they occur. Both
processes are unusual enough, however, that predictions
are difficult to make. 
As the B cell, class switch and somatic hypermutation fields
consider these dramatic and important findings, many new
avenues have been opened by the discovery of AID. It is
not possible at this time to know the precise role of this
enzyme in the DNA or B-cell developmental events, but it
is clear that identification of AID is a major advance that will
be of both basic and clinical importance in the long term. 
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